This inventor holds 1 USPTO granted patent. Top assignees: Phoenixbio Co., Ltd., Tottori University. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2016
Title: Takashi Shimada: Innovator in Chimeric Non-Human Animal Research
Introduction
Takashi Shimada is a prominent inventor based in Higashihiroshima, Japan. He is known for his groundbreaking work in the field of biotechnology, particularly in the development of chimeric non-human animals that carry human hepatocytes. His innovative research has significant implications for drug metabolism studies and therapeutic applications.
Latest Patents
Shimada holds a patent for a "Chimeric non-human animal carrying human hepatocyte." This invention provides a chimeric non-human animal that has an in vivo human hepatocyte population. The patent addresses the suppression or deletion of the effects of non-human animal cells on drug metabolism. The method for producing such an animal involves transplanting human hepatocytes into a non-human animal that is immunodeficient, has liver damage, and lacks the functions of an endogenous Cyp3a gene. This advancement opens new avenues for research in drug metabolism and human liver function.
Career Highlights
Throughout his career, Takashi Shimada has made significant contributions to the field of biotechnology. He has worked with notable organizations, including Phoenixbio Co., Ltd. and Tottori University. His research has been instrumental in advancing the understanding of human liver function and its implications for drug development.
Collaborations
Shimada has collaborated with esteemed colleagues such as Mitsuo Oshimura and Yasuhiro Kazuki. These partnerships have fostered a collaborative environment that enhances the quality and impact of his research.
Conclusion
In summary, Takashi Shimada is a distinguished inventor whose work in chimeric non-human animals has the potential to revolutionize drug metabolism research. His innovative approaches and collaborations continue to contribute to advancements in biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile